Recent Finacing
Recent Raise
Blue Earth Therapeutics is an Oxford-based clinical-stage company developing PSMA-targeted radioligand therapies and other targeted radiopharmaceuticals, with an initial pipeline focused on prostate cancer and incubated within Bracco.
